Vistagen Therapeutics, Inc. (VTGN) — DEF 14A Filings
All DEF 14A filings from Vistagen Therapeutics, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Vistagen's Executive Pay Leans Heavily on Equity Incentives
— Jul 28, 2025 Risk: medium
Vistagen Therapeutics, Inc. (VTGN) filed its DEF 14A on July 28, 2025, outlining executive compensation and governance matters for the fiscal year ended March 3 -
Vistagen Therapeutics Files DEF 14A, Details Executive Compensation
— Jul 17, 2024 Risk: low
Vistagen Therapeutics, Inc. filed a DEF 14A on July 17, 2024, detailing executive compensation and corporate governance for the fiscal year ending March 31, 202 -
Vistagen Therapeutics to Hold Virtual Special Meeting of Stockholders on May 29, 2024
— Apr 16, 2024 Risk:
Vistagen Therapeutics, Inc. (VTGN) filed a Proxy Statement (DEF 14A) with the SEC on April 16, 2024. Vistagen Therapeutics, Inc. will hold a virtual special mee
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX